Lymphatics unload VEGFR3 in response to the alteration of VEGFR2-mediated transcriptional programs

Taotao Li, Xudong Cao, Zhou Fei, Xiujuan Li, Wenjuan Ma, Haoyu Zhong, Beibei Xu, Michael Chu, Xiwen Jia, Kai Ding, Xin Shen, Yali Liu, Yun Zhao, Zheng Zhang, Junhao Hu, Young‐Kwon Hong, Lena Claesson‐Welsh, Yulong HebioRxiv 2025 · DOI

TL;DR

While VEGFR2 is the "famous" regulator of blood vessel growth, this study reveals it is also a critical guardian of lymphatic identity. Deleting VEGFR2 triggers an "endothelial stress" response that causes lymphatic cells to rapidly degrade VEGFR3 protein—the primary driver of lymphatic growth—effectively stalling the development of the lymphatic network and its valves.

What Problem Does This Paper Address?

In the world of vascular biology, roles are often strictly partitioned: VEGFR2 handles blood vessels (angiogenesis), while VEGFR3 handles lymphatics (lymphangiogenesis). However, lymphatic endothelial cells (LECs) actually express both. While we know these receptors can pair up as heterodimers, the specific requirement for VEGFR2 in the lymphatic system has remained a "black box."

The authors sought to determine if VEGFR2 is merely a backup player or an essential component for maintaining LEC identity and driving the formation of complex structures like lymphatic valves and "button-like" junctions (specialized openings that allow fluid entry).

Methods

The researchers employed a multi-pronged approach combining sophisticated mouse genetics with high-throughput sequencing:

  • Inducible Genetic Deletion: They used two mouse models to delete the Vegfr2 gene at specific times (neonatal and juvenile stages). One model targeted all endothelial cells (Cdh5-CreERT2), while the other specifically targeted lymphatics (Prox1-CreERT2).
  • Transcriptomics (RNA-seq): They performed RNA sequencing on skin tissues at various intervals (48 hours, 96 hours, and several weeks post-deletion) to capture the immediate molecular "panic" versus long-term structural changes.
  • In Vitro Validation: To prove the effects were "cell-autonomous" (happening within the LECs themselves rather than due to external factors), they used siRNA to knock down VEGFR2 in primary cultured mouse LECs.
  • High-Resolution Imaging: Whole-mount immunostaining and confocal microscopy were used to visualize vessel diameters, valve counts, and protein localization.

Datasets

  • Primary RNA-seq Data: Generated from murine ear skin (P21) and abdominal skin (P3) tissues.
  • Reference Atlases: The study utilized the Transcriptome Atlas of Murine Endothelial Cells (Kalucka et al.) and the Molecular Signatures Database (MSigDB) for Gene Set Enrichment Analysis (GSEA).
  • Data Availability: The authors state that raw and processed RNA-seq data will be deposited in the Gene Expression Omnibus (GEO).

Key Insights and Ideas

  • The Protein-mRNA Disconnect: One of the most striking findings was that while VEGFR3 protein levels plummeted after VEGFR2 loss, the Vegfr3 mRNA levels remained relatively stable. This suggests that VEGFR2 isn't just helping "turn on" the VEGFR3 gene; it is actively preventing the VEGFR3 protein from being trashed by the cell's internal disposal systems.
  • Endothelial Stress Response: Losing VEGFR2 doesn't just stop growth; it flips a molecular switch. The cells enter a state of "endothelial stress," upregulating pathways related to apoptosis (cell death), inflammation (NFκB), and protein degradation (proteasomal and lysosomal pathways).
  • Identity Crisis: The authors propose that VEGFR2 is essential for maintaining "LEC identity." Without it, the cells lose their specialized markers and begin to express genes associated with immune responses and proteolytic activity, hinting at a potential (though not fully realized) transition toward a hematopoietic-like state.
  • Valve Vulnerability: VEGFR2 is highly concentrated in lymphatic valves. Its absence specifically cripples the remodeling of the primary lymphatic plexus into a mature network of valve-containing collecting vessels.

Key Results

  • Structural Defects: Deleting Vegfr2 led to significantly thinner lymphatic vessels, a decrease in the total number of LECs, and a dramatic reduction in lymphatic valves.
  • Molecular Signature: RNA-seq revealed a massive downregulation of lymphangiogenic genes (Sox18, Lyve1, Foxc2) and an enrichment of GO terms for "endothelial cell apoptotic process" and "inflammatory response."
  • Rapid Response: The loss of VEGFR3 protein was detectable as early as 48 to 96 hours after inducing the Vegfr2 deletion, highlighting how quickly the system destabilizes without VEGFR2.
  • Functional Confirmation: siRNA knockdown in primary LECs confirmed that reducing VEGFR2 directly leads to a decrease in surface VEGFR3, proving this isn't just a side effect of a failing blood vascular system.

Limitations and Future Work

  • The "How" of Degradation: While the paper identifies that protein degradation pathways are upregulated, the specific molecular "executioner" (e.g., a specific E3 ligase or protease) that targets VEGFR3 for destruction remains unknown.
  • Blood-Lymph Interplay: In the pan-endothelial deletion model, blood vessel defects occur alongside lymphatic ones. While the authors used lymphatic-specific models to isolate the effects, the complex crosstalk between these two systems in a living organism—especially during disease—requires further exploration.
  • Therapeutic Caution: The study warns that clinical drugs targeting VEGFR2 (often used in cancer to starve tumors of blood) might inadvertently damage the lymphatic system by "unloading" VEGFR3, potentially leading to side effects like lymphedema. Future work could look for ways to protect lymphatic VEGFR2 during anti-angiogenic therapy.

Summary updated

Abstract

Abstract Vascular endothelial growth factor receptor 2 (VEGFR2) is a key target for regulating the endothelial cell lineage and angiogenesis. It is also expressed by lymphatic endothelial cells (LEC) while its participation in the process of lymphangiogenesis remains inadequately characterized. We show in this study that VEGFR2 is highly expressed in dermal initial lymphatic vessels and valves. The induced deletion of pan-endothelial Vegfr2 at the neonatal stage produced a potent suppression of dermal lymphatic growth, including the thinner lymphatic diameter, the decrease of LEC number and lymphatic valves. Mechanistically, the VEGFR2 insufficiency led to a dramatic decrease of lymphatic VEGFR3, a key regulator mediating signals for lymphatic growth and remodeling. The RNA sequencing analysis revealed that GO terms enriched for the downregulated genes included biological processes related to the EC development while pathways related to the hematopoiesis and immune responses were upregulated in the skin of Vegfr2 mutants compared with the littermate controls. This was further confirmed by the RNA-seq analysis of dermal tissues 48 hours after the endothelial Vegfr2 deletion. Consistently, an inhibitory effect on the dermal lymphatic growth was also observed by targeting Vegfr2 in PROX1 + cells, manifesting a similarly altered transcriptome signature. The alteration of lymphatic gene expression was further validated by the siRNA mediated knockdown of Vegfr2 in primary lymphatic endothelial cells, showing a transcriptional trend of LEC to hematopoietic transition. Findings from this study imply that VEGFR2 is required for the maintenance of endothelial identity and its insufficiency may trigger the alteration of lymphatic transcriptional programs to diminish the VEGFR3-mediated lymphangiogenesis.
BibTeX
@misc{li2025lymphatics,
  author = {Taotao Li and Xudong Cao and Zhou Fei and Xiujuan Li and Wenjuan Ma and Haoyu Zhong and Beibei Xu and Michael Chu and Xiwen Jia and Kai Ding and Xin Shen and Yali Liu and Yun Zhao and Zheng Zhang and Junhao Hu and Young‐Kwon Hong and Lena Claesson‐Welsh and Yulong He and Yulong He},
  title = {{Lymphatics unload VEGFR3 in response to the alteration of VEGFR2-mediated transcriptional programs}},
  year = {2025},
  doi = {10.1101/2025.10.20.683599},
  howpublished = {bioRxiv},
}
Figure